Question: What is the name of the virus that was recreated in a lab in 1918?
About the article "Virus", section "Weapons".

Candidate passages:
Mavirus virophage is a double stranded DNA virus that infects the marine phagotropic flagellate "Cafeteria roenbergensis" in the presence of a second virus — Cafeteria roenbergensis virus.
The name is derived from Maverick virus.
The virophage was discovered by Fischer while he was working on Cafeteria roenbergensis virus as part of his PhD. 
Phylogenetic analysis can help determine past viruses and their patterns as well as determining a common ancestor of the virus.
Past studies reveal that an avian virus spread to pigs and then to humans approximately 100 years ago.
This resulted in human lineages further evolving and becoming more prominent and stable.
Analysis can also feature relationships between species.
The 1918 Spanish influenza virus demonstrates this.
The hemagglutinin (HA) gene of the 1918 pandemic virus was closer in sequence to avian strains than other mammalian ones.
Despite this genetic similarity, it is obviously a mammalian virus.
The gene may have been adapting in humans even prior to 1918.
Breaking down the phylogenetic history of the influenza virus shows that there is a common ancestor that reaches back before the 1918 outbreak that links the current human virus to the swine virus.
The ancestor was derived from an avian host. 
  Six-page human-interest story on the recreation of the deadly 1918 H1N1 flu virus  Results from analyzing a recreated strain.
Data from   Oral history by 1918 pandemic survivor  
Kaspersky then worked at a multi-discipline scientific research institute.
It was here where he first began studying computer viruses after detecting the Cascade virus in 1989.
After analyzing the virus, Kaspersky developed a disinfection utility for it – the first of many to come.
Cascade was the first malicious program to enter what is now the Kaspersky Lab Antivirus Database, which today contains well over 100 million samples of malware.
Kaspersky joined the KAMI Information Technologies Center in 1991, where he and his associates developed the AVP anti-virus product.
Eugene was responsible for AVP becoming the first antivirus software in the world to separate the software from the antivirus database – standard for the industry today.
He also came up with the idea of giving AVP the world’s first antivirus graphic user interface.
In November 1992, the team released its first fully-fledged product – AVP 1.0.
In 1994 the product came top in comparative testing conducted by the University of Hamburg’s test lab by demonstrating higher virus detection and neutralization rates than the most popular antivirus programs of the day.
This surprise win brought AVP widespread international recognition.
Around this time the team began to license its unique expert know-how out to foreign IT firms – a practice that continues today (more than 80 companies license technologies from Kaspersky Lab).
In 1997, Eugene and his colleagues decided to register an independent company and became the founders of Kaspersky Lab.
Initially Eugene didn’t want to use his name in the title, but he was eventually persuaded to do so by then-wife Natalya Kaspersky– also a co-founder.
In November 2000, AVP was renamed 'Kaspersky Anti-Virus' after a dispute with a US partner.
From the establishment of the company until 2007, Eugene Kaspersky was head of the company’s antivirus research.
In 2007, Eugene was named the CEO of Kaspersky Lab.
Today, Kaspersky concentrates on the strategic management of the company, which sees him frequently traveling the globe – public speaking at major conferences and exhibitions, attending international meetings and partner conferences, and giving interviews to the press.
Besides being the CEO of the world’s largest privately held Internet security firm, Kaspersky’s strong technical background and experience ensure that he is a highly sought-after speaker at different types of events around the world.
His office is located next to the company’s research experts - members of the Global Research and Analysis Team (GReAT), and just a few meters from the nerve center of Kaspersky Lab HQ – the Virus Lab – on the same floor as the company’s senior developers and analysts.
He still regards himself as a technical specialist, at home among technical experts and fully conversant with their trade.
Kaspersky is a co-author of several patents, including one for a constraint-and-attribute-based security system for controlling software component interaction.
This patent covers the technology that sits at the heart of Kaspersky Lab’s secure operating system, which is currently in development. 
Impatiens necrotic spot virus (INSV) is a plant pathogenic virus of the family "Bunyaviridae".
It was originally believed to be another strain of "Tomato spotted wilt virus" but genetic investigations revealed them to be separate viruses.
It is a single stranded RNA It has a tripartate genome and is largely spread by the insect vector of the western flower thrips.
The virus infects more than 648 species of plant including important horticultural and agricultural species such as fuchsia, tomato, orchids, and lettuce (especially romaine).
As the name implies, the main symptom on plants is necrotic spots that appear on the leaves.
The INSV virus infects by injecting the RNA the virus contains into the cell which then starts using the cell resources to transcribe what the virus RNA states.
Viral infection can often result in the death of the plant.
The disease is mainly controlled by the elimination of the western flower thrip vector and by destroying any infected plant material.